ONCY: Oncolytics Biotech Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 73.21
Enterprise Value ($M) n/a
Book Value ($M) 9.06
Book Value / Share 0.12
Price / Book n/a
NCAV ($M) 7.71
NCAV / Share 0.10
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -2.73
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 2.99
Current Ratio 2.99

Balance Sheet (mrq) ($M)
Current Assets 22.91
Assets 24.26
Liabilities 15.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 33,134 151,836 21.82
2024-11-26 48,069 133,938 35.89
2024-11-25 58,640 192,108 30.52
2024-11-22 131,633 344,925 38.16

(click for more detail)

Similar Companies
OKYO – OKYO Pharma Limited ONCO – Onconetix, Inc.
ONCT – Oncternal Therapeutics, Inc. ONVO – Organovo Holdings, Inc.
ORGO – Organogenesis Holdings Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.